Aerosolized surfactant therapy for endotoxin-induced experimental acute respiratory distress syndrome in rats.
We have compared the effects of inhalation of aerosolized surfactant on experimental acute respiratory distress syndrome. Escherichia coli endotoxin (55 (SD 20) mg kg(-1)) was injected into the tracheas of 36 adult rats anaesthetized and mechanically ventilated with pure oxygen. When the Pa(O(2)) decreased to 11.3 (3.3) kPa, the animals were randomly subjected to inhalation of aerosolized modified natural surfactant (MNS) for 0 min (control group), 30, 60, and 120 min. In the control group, Pa(O(2)) remained below 12 kPa for 180 min. In the groups receiving inhalation of surfactant for 30 and 60 min, Pa(O(2)) increased but decreased soon after termination of the inhalation. In contrast, Pa(O(2)) of the group receiving inhalation of surfactant for 120 min continued to increase, reaching 52.1 (12.5) kPa at 180 min (P<0.05 vs control). Thus, we conclude that improvement in gas exchange as a result of inhalation of MNS depends on the duration of inhalation.
Tashiro
K
K
Department of Anesthesiology and Intensive Care Medicine, School of Medicine, Kanazawa University, Kanazawa, Japan.
Yamada
K
K
Konzaki
T
T
Yamamoto
K
K
Ohmura
S
S
Kobayashi
T
T
Suzuki
Y
Y
D000336:Aerosols; D000818:Animals; D001835:Body Weight; D018893:Bronchoalveolar Lavage; D002245:Carbon Dioxide / Q000097:blood; D004334:Drug Administration Schedule; D004731:Endotoxins; D008168:Lung / Q000473:pathology; D008297:Male; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D011663:Pulmonary Surfactants / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D012128:Respiratory Distress Syndrome / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D013552:Swine
D000336:Aerosols; D004731:Endotoxins; D011663:Pulmonary Surfactants; D002245:Carbon Dioxide; D010100:Oxygen